Literature DB >> 19274366

How to establish a successful revolving drug fund: the experience of Khartoum state in the Sudan.

Gamal Khalafalla Mohamed Ali1.   

Abstract

PROBLEM: During the 1990s, the Sudan began several initiatives to establish new medicine-financing mechanisms as part of the health reform process. Initial seed stocks were provided to each hospital. Unfortunately these facility-based funds did not regenerate and the hospitals were left without funds for medicines. The Revolving Drug Fund (RDF) was established in 1989 to facilitate access to medicines in health facilities in Khartoum state. APPROACH: This study used quantitative and qualitative research techniques to collect data from health-care providers and users to evaluate the experience of operating an RDF in Khartoum state. Data from personal observations and from archival and statistical records were also analysed. Seven health facilities were sampled for this research. LOCAL
SETTING: The Ministry of Health has a policy to expand the RDF to the whole country and has already commenced roll-out to seven more states. This policy is based on the experience of the RDF within Khartoum state. RELEVANT CHANGES: Khartoum state has a high (97%) level of availability of essential medicines and this is attributed to the RDF. The RDF medicines were mostly considered affordable by users and very few (6%) patients failed to obtain the prescribed medicines for financial reasons. LESSONS LEARNED: The RDF could be successfully replicated in other states of the Sudan and in low-income countries with similar contexts on condition that they meet success factors, such as gradual implementation, political commitment and availability of hard currency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19274366      PMCID: PMC2636186          DOI: 10.2471/blt.07.048561

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  The behaviour of health workers in an era of cost sharing: Ghana's drug cash and carry system.

Authors:  W K Asenso-Okyere; I Osei-Akoto; A Anum; A Adukonu
Journal:  Trop Med Int Health       Date:  1999-08       Impact factor: 2.622

2.  Revolving drug funds: a step towards health security.

Authors:  T Umenai; I S Narula
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

3.  Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria.

Authors:  Benjamin S C Uzochukwu; Obinna E Onwujekwe; Cyril O Akpala
Journal:  Health Policy Plan       Date:  2002-12       Impact factor: 3.344

4.  Financially independent primary health care drug supply system in Cameroun.

Authors:  F von Massow; R Korte; C Cheka; M Kuper; H Tata; B Schmidt-Ehry
Journal:  Trop Med Int Health       Date:  1998-10       Impact factor: 2.622

5.  Revolving drug funds at front-line health facilities in Vientiane, Lao PDR.

Authors:  H Murakami; B Phommasack; R Oula; S Sinxomphou
Journal:  Health Policy Plan       Date:  2001-03       Impact factor: 3.344

6.  User fees and drug pricing policies: a study at Harare Central Hospital, Zimbabwe.

Authors:  E Chisadza; C C Maponga; H Nazerali
Journal:  Health Policy Plan       Date:  1995-09       Impact factor: 3.344

  6 in total
  7 in total

1.  Stakeholder perspectives to inform adaptation of a hypertension treatment program in primary healthcare centers in the Federal Capital Territory, Nigeria: a qualitative study.

Authors:  Rosemary C B Okoli; Gabriel Shedul; Lisa R Hirschhorn; Ikechukwu A Orji; Tunde M Ojo; Nonye Egenti; Kasarachi Omitiran; Blessing Akor; Abigail S Baldridge; Mark D Huffman; Dike Ojji; Namratha R Kandula
Journal:  Implement Sci Commun       Date:  2021-08-30

2.  Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan.

Authors:  Brenda Waning; Jason Maddix; Lyne Soucy
Journal:  BMC Health Serv Res       Date:  2010-07-13       Impact factor: 2.655

3.  Wilms' tumour in African children: Can an institutional approach improve outcome?

Authors:  Lofty-John Chukwuemeka Anyanwu; Lofty-John Chukwuemeka Anyanwa; Akinfenwa Taoheed Atanda; Jareenat Oladoyin Atanda
Journal:  Afr J Paediatr Surg       Date:  2015 Jan-Mar

4.  Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan.

Authors:  Brenda Waning; Jason Maddix; Yorghos Tripodis; Richard Laing; Hubert Gm Leufkens; Manjusha Gokhale
Journal:  Int J Equity Health       Date:  2009-12-14

Review 5.  Access to medicines from a health system perspective.

Authors:  Maryam Bigdeli; Bart Jacobs; Goran Tomson; Richard Laing; Abdul Ghaffar; Bruno Dujardin; Wim Van Damme
Journal:  Health Policy Plan       Date:  2012-11-22       Impact factor: 3.344

6.  Assessment of a revolving drug fund for essential asthma medicines in Benin.

Authors:  Gildas Agodokpessi; Nadia Aït-Khaled; Martin Gninafon; Leon Tawo; Wilfried Bekou; Christophe Perrin; Karen Bissell; Nils Billo; Donald A Enarson; Chen-Yuan Chiang
Journal:  J Pharm Policy Pract       Date:  2015-04-13

7.  Solving the problem of access to cardiovascular medicines: revolving fund pharmacy models in rural western Kenya.

Authors:  Dan N Tran; Imran Manji; Rajesh Vedanthan; Sonak Pastakia; Benson Njuguna; Jemima Kamano; Jeremiah Laktabai; Edith Tonui
Journal:  BMJ Glob Health       Date:  2020-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.